IUHSA
BPMC

Itau Unibanco Holding S.A.’s Blueprint Medicines BPMC Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$5.39K – 345
2024
Q2 		$5.39K Buy
+50
New +$5K ﹤0.01% 313
2024
Q1 		– Sell
-79
Closed -$7.29K – 162
2023
Q4 		$7.29K Sell
79
-21
-21% -$1.36K ﹤0.01% 327
2023
Q3 		$5.02K Sell
100
-1
-1% -$53 ﹤0.01% 448
2023
Q2 		$6.38K Sell
101
-12
-11% -$652 ﹤0.01% 482
2023
Q1 		$5.08K Hold
113
– – ﹤0.01% 479
2022
Q4 		$4.95K Sell
113
-9
-7% -$432 ﹤0.01% 488
2022
Q3 		$8K Hold
122
– – ﹤0.01% 497
2022
Q2 		$6K Buy
+122
New +$7.15K ﹤0.01% 439
2021
Q4 		– Sell
-216
Closed -$22K – 413
2021
Q3 		$22K Buy
216
+6
+3% +$559 ﹤0.01% 329
2021
Q2 		$18K Buy
+210
New +$19.2K ﹤0.01% 306

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BPMC Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Blueprint Medicines (BPMC) in Q3 2024, closing a stake of 50 shares — an estimated $5.39K sold.

Itau Unibanco Holding S.A. first reported a position in BPMC in Q2 2021 and held it in 10 quarters. The position peaked at $22K in Q3 2021. 319 funds tracked by Wall St. Rank hold BPMC as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Blueprint Medicines position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 50 Blueprint Medicines shares in Q3 2024, an estimated $5.39K.
  • Itau Unibanco Holding S.A. first reported a position in Blueprint Medicines in Q2 2021 and held it in 10 quarters.
  • Itau Unibanco Holding S.A.'s Blueprint Medicines position peaked at $22K in Q3 2021.
  • 319 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.